50 Studies Every Endocrinologist Should Know

John Interlandi, MD, is a distinguished specialist in Endocrinology, Diabetes & Metabolism, and Internal Medicine. He is a graduate of the Vanderbilt University School of Medicine and completed his Internal Medicine Residency at the Medical College of Wisconsin in Milwaukee. He further honed his expertise through an Endocrine Fellowship at Vanderbilt and Nashville VA Hospitals.Dr. Interlandi has served in various academic roles, including Assistant Clinical Professor of Medicine and Associate Clinical Professor of Medicine at Vanderbilt University. His professional journey also includes significant contributions to medical research and clinical trials. He directed the Hepatic Activation Program at Donelson Hospital from 1992 to 1993 and led the Implantable Insulin Pump Project at the same hospital from 1988 to 1994. Additionally, he was involved in the Glyburide Multicenter Trial with Hoechst Pharmaceuticals and conducted Thyroid Biopsy Molecular Analysis Research at Summit Hospital.Dr. Interlandi has shared his knowledge through invited lectures on Thyroid Ultrasound at the AACE Course in Nashville. He also served on the Eli Global Advisory Board Currently, he works as a Medical Director practicing in Tennessee.

• SECTION 1: Conditions caused by Thyroid Damage Chapter 1: Screening for Thyroid Disease in Early Pregnancy and in Pre-PregnancyChapter 2: Subclinical HypothyroidismChapter 3: Management of Thyroxine in Non-Ablated Patients with HypothyroidismChapter 4: Optimal Thyroid Replacement for the Athyreotic Patient SECTION 2: Conditions Causing Thyroid Overactivity Chapter 5: Antithyroid Drugs vs. Ablation in Community Treatment for Graves> ' DiseaseChapter 6: Optimum Use of Antithyroid Drugs in HyperthyroidismChapter 7: Risks of I-131 Treatment of HyperthyroidismChapter 8: Hyperthyroidism caused by Amiodarone (AIT) SECTION 3: Focal and Structural Thyroid Disease Chapter 9: Selection of Thyroid Nodules to be BiopsiedChapter 10: Selection of Patients over 45 for Thyroid BiopsyChapter 11: Molecular Genomic Testing (MGT) for Indeterminate Thyroid NodulesChapter 12: Complication Rate(s) from ThyroidectomyChapter 13: Ablation Techniques for Benign or Hot NodulesChapter 14: Microscopic Papillary Thyroid Carcinoma (mPTC) and Active Surveillance (AS)Chapter 15: Optimal Work-up and Surgery for a small, non-metastatic DTCAChapter 16: I-131 Treatment for DTCA SECTION 4: Parathyroid Diseases Chapter 17: Active Surveillance and/or Medical Therapy for Hyperparathyroidism in Older PatientsChapter 18: Preoperative Localization of Sporadic Primary HyperparathyroidismChapter 19: Quality of Life after Surgery for Mild/Moderate Sporadic Primary HyperparathyroidismChapter 20: Secondary Hyperparathyroidism, Idiopathic Hypercalciuria, and Bone DensityChapter 21: Recurrent and/or Persistent Primary Hyperparathyroidism SECTION 5: Metabolic Bone Disease Chapter 22: Calcium and Vitamin D Effects on Bone MassChapter 23: Fracture Prevention in Patients with Low Bone MassChapter 24: Pretreatment Evaluation for OsteoporosisChapter 25: Evaluation of Fracture Risk in OsteoporosisChapter 26: Osteoporosis and Hip Fracture PreventionChapter 27: Alendronate and Fracture Risk ReductionChapter 28: Hip Fracture in the Elderly with Very Low Bone DensityChapter 29: Anabolic Agent(s) for OsteoporosisChapter 30: Glucocorticoid OsteoporosisChapter 31: Osteoporosis in Men SECTION 6: Adrenal Conditions Chapter 32: The Importance of Recognizing HyperaldosteronismChapter 33: Effectiveness of Treatment of HyperaldosteronismChapter 34: Screening for Adrenal InsufficiencyChapter 35: Adrenal IncidentalomasChapter 36: Opioid-Induced Endocrine DeficienciesChapter 37: Adrenal Insufficiency from Corticosteroid TreatmentChapter 38: Optimal Testing for ACTH-Dependent Hypercortisolism SECTION 7: Pituitary Tumors / Hypercortisolism Chapter 39: Duration of Medical Treatment of Intrasellar ProlactinomasChapter 40: Acromegaly Treatment-Surgery, Medication, or What?Chapter 41: Primary Treatment of Pituitary HypercortisolismChapter 42: Treatment of Recurrent or Persistent Hypercortisolism SECTION 8: Conditions Caused by Testosterone Deficiency Chapter 43: Risks of Testosterone Treatment in Older MenChapter 44: Male Obesity Secondary Hypogonadism (MOSH) SECTION 9: Conditions Related to Estrogen Deficiency Chapter 45: Estrogen Treatment and Cardiovascular HealthChapter 46: Estrogen Treatment and Skeletal HealthChapter 47: Estrogen + Progestin vs. Estrogen Alone, and Neoplasia SECTION 10: Polycystic Ovary Syndrome Chapter 48: Optimal Differential Diagnosis of PCOSChapter 49: Optimal Treatment of Hirsutism in PCOS Chapter 50: Treatment of Subfertility in PCOS